Company: AZN
Filing Date: 2025-07-29
Form Type: 6-K
Source: 0001104659-25-071432
Chunk: 21

Company: ASTRAZENECA PLC
Filing Date: 2025-07-29
Form: 6-K
Chunk 21
---
 ​ |  5,429 | ​ |  5,637 |
| Exchange rate effects                                                               | ​ |     54 | ​ |    -52 |
| Cash and cash equivalents at the end of the period                                  | ​ |  7,032 | ​ |  6,677 |
| ​                                                                                   | ​ |      ​ | ​ |      ​ |
| Cash and cash equivalents consist of:                                               | ​ |      ​ | ​ |      ​ |
| Cash and cash equivalents                                                           | ​ |  7,058 | ​ |  6,916 |
| Overdrafts                                                                          | ​ |    -26 | ​ |   -239 |
| ​                                                                                   | ​ |  7,032 | ​ |  6,677 |

33

Responsibility statement of the directors in respect of the half-yearly financial report We confirm that to the best of our knowledge:

| ‒ | the condensed consolidated Interim Financial Statements have been prepared in accordance with IAS 34 ‘Interim Financial Reporting’ as issued by the International Accounting Standards Board (IASB), IAS 34 as adopted by the European Union and UK-adopted IAS 34; |

| ‒ | the half-yearly management report gives a true and fair view of the assets, liabilities, financial position and profit or loss of the company; |

| ‒ | the half-yearly management report includes a fair review of the information required by: |

| a) | DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed consolidated Interim Financial Statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and |

| b) | DTR 4.2.8R of the Disclosure and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the enterprise during that period; and any changes in the related party transactions described in the last annual report that could do so. |

The Board The Board of Directors that served during all or part of the six month period to 30 June 2025 and their respective responsibilities can be found on the Leadership team section of astrazeneca.com . Approved by the Board and signed on its behalf by Pascal Soriot Chief Executive Officer 29 July 2025

34